Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.21.2
Condensed Statements of Cash Flows - USD ($)
1 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ (11,074) $ 1,991,985
Adjustments to reconcile net income to net cash used in operating activities:    
Change in fair value of derivative warrant liabilities 0 (3,419,833)
Changes in operating assets and liabilities:    
Prepaid expenses 0 (74,219)
Accrued expenses 0 17,766
Accounts payable 11,074 (582,140)
Due to related parties 0 90,000
Dividend income 0 (18,127)
Net cash used in operating activities 0 (1,994,568)
Cash Flows from Financing Activities:    
Payment of offering costs 0 (70,679)
Proceeds of note payable from related parties 0 1,250,000
Net cash provided by financing activities 0 1,179,321
Net decrease in cash 0 (815,247)
Cash – Beginning of the period 0 1,044,177
Cash – End of the period 0 $ 228,930
Supplemental disclosure of noncash investing and financing activities:    
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares 25,000  
Deferred offering costs included in accrued expenses 294,140  
Deferred offering costs included in note payable $ 60,875